The impact of dual antiplatelet therapy duration on primary composite endpoint after drug-eluting stent implantation: A meta-analysis of 10 randomized trials — Si Pang (2015) | RDL Network
The impact of dual antiplatelet therapy duration on primary composite endpoint after drug-eluting stent implantation: A meta-analysis of 10 randomized trials
Eliano Pio Navarese, Felicita Andreotti, Volker Schulze, M. Ko odziejczak, Antonino Buffon, Marc A. Brouwer, Francesco Costa, Mariusz Kowalewski, Gianfranco Parati, Professor Gregory Lip, Malte Kelm, Marco Valgimigli
Yao‐Jun Zhang, Javaid Iqbal, Christos V. Bourantas, Shaoliang Chen, Héctor M. García‐García, Takashi Muramatsu, Patrick W. Serruys, Dong Sheng-Jie, Bo Xu
Sorin J. Brener, Patrick W. Serruys, Martin B. Leon, Marie‐Claude Morice, David E. Kandzari, Roxana Mehran, A. Pieter Kappetein, Joseph F. Sabik, Yangbo Liu, Ovidiu Dressler, Ori Ben‐Yehuda, Gregg W. Stone
Discussion(0)
No comments yet. Be the first to comment.